These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 19010906

  • 41. Bortezomib induces autophagic death in proliferating human endothelial cells.
    Belloni D, Veschini L, Foglieni C, Dell'Antonio G, Caligaris-Cappio F, Ferrarini M, Ferrero E.
    Exp Cell Res; 2010 Apr 01; 316(6):1010-8. PubMed ID: 19917281
    [Abstract] [Full Text] [Related]

  • 42. Bortezomib induces autophagy in head and neck squamous cell carcinoma cells via JNK activation.
    Li C, Johnson DE.
    Cancer Lett; 2012 Jan 01; 314(1):102-7. PubMed ID: 21993018
    [Abstract] [Full Text] [Related]

  • 43. Oncogenic B-RAF signaling in melanoma impairs the therapeutic advantage of autophagy inhibition.
    Armstrong JL, Corazzari M, Martin S, Pagliarini V, Falasca L, Hill DS, Ellis N, Al Sabah S, Redfern CP, Fimia GM, Piacentini M, Lovat PE.
    Clin Cancer Res; 2011 Apr 15; 17(8):2216-26. PubMed ID: 21270111
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors.
    Golden EB, Lam PY, Kardosh A, Gaffney KJ, Cadenas E, Louie SG, Petasis NA, Chen TC, Schönthal AH.
    Blood; 2009 Jun 04; 113(23):5927-37. PubMed ID: 19190249
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Global cellular response to chemotherapy-induced apoptosis.
    Wiita AP, Ziv E, Wiita PJ, Urisman A, Julien O, Burlingame AL, Weissman JS, Wells JA.
    Elife; 2013 Oct 29; 2():e01236. PubMed ID: 24171104
    [Abstract] [Full Text] [Related]

  • 49. The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571.
    Yu C, Rahmani M, Conrad D, Subler M, Dent P, Grant S.
    Blood; 2003 Nov 15; 102(10):3765-74. PubMed ID: 12893773
    [Abstract] [Full Text] [Related]

  • 50. Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib.
    Kardosh A, Golden EB, Pyrko P, Uddin J, Hofman FM, Chen TC, Louie SG, Petasis NA, Schönthal AH.
    Cancer Res; 2008 Feb 01; 68(3):843-51. PubMed ID: 18245486
    [Abstract] [Full Text] [Related]

  • 51. ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells.
    Wang Q, Mora-Jensen H, Weniger MA, Perez-Galan P, Wolford C, Hai T, Ron D, Chen W, Trenkle W, Wiestner A, Ye Y.
    Proc Natl Acad Sci U S A; 2009 Feb 17; 106(7):2200-5. PubMed ID: 19164757
    [Abstract] [Full Text] [Related]

  • 52. Doxorubicin prevents endoplasmic reticulum stress-induced apoptosis.
    Kim SJ, Park KM, Kim N, Yeom YI.
    Biochem Biophys Res Commun; 2006 Jan 13; 339(2):463-8. PubMed ID: 16298333
    [Abstract] [Full Text] [Related]

  • 53. Increased sensitivity to apoptosis upon endoplasmic reticulum stress-induced activation of the unfolded protein response in chemotherapy-resistant malignant pleural mesothelioma.
    Xu D, Liang SQ, Yang H, Lüthi U, Riether C, Berezowska S, Marti TM, Hall SRR, Bruggmann R, Kocher GJ, Schmid RA, Peng RW.
    Br J Cancer; 2018 Jul 13; 119(1):65-75. PubMed ID: 29921948
    [Abstract] [Full Text] [Related]

  • 54. Dissecting apoptosis the omics way.
    Van Damme P.
    Elife; 2013 Nov 12; 2():e01587. PubMed ID: 24220511
    [Abstract] [Full Text] [Related]

  • 55. Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity.
    Mimnaugh EG, Xu W, Vos M, Yuan X, Isaacs JS, Bisht KS, Gius D, Neckers L.
    Mol Cancer Ther; 2004 May 12; 3(5):551-66. PubMed ID: 15141013
    [Abstract] [Full Text] [Related]

  • 56. The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib.
    Milani M, Rzymski T, Mellor HR, Pike L, Bottini A, Generali D, Harris AL.
    Cancer Res; 2009 May 15; 69(10):4415-23. PubMed ID: 19417138
    [Abstract] [Full Text] [Related]

  • 57. Ritonavir interacts with bortezomib to enhance protein ubiquitination and histone acetylation synergistically in renal cancer cells.
    Sato A, Asano T, Ito K, Asano T.
    Urology; 2012 Apr 15; 79(4):966.e13-21. PubMed ID: 22296623
    [Abstract] [Full Text] [Related]

  • 58. The combination of proteasome inhibitors bortezomib and gambogic acid triggers synergistic cytotoxicity in vitro but not in vivo.
    Liu N, Huang H, Xu L, Hua X, Li X, Liu S, Yang C, Zhao C, Zhao C, Li S, Dou QP, Liu J.
    Toxicol Lett; 2014 Jan 30; 224(3):333-40. PubMed ID: 24291039
    [Abstract] [Full Text] [Related]

  • 59. Bortezomib induces protective autophagy through AMP-activated protein kinase activation in cultured pancreatic and colorectal cancer cells.
    Min H, Xu M, Chen ZR, Zhou JD, Huang M, Zheng K, Zou XP.
    Cancer Chemother Pharmacol; 2014 Jul 30; 74(1):167-76. PubMed ID: 24842158
    [Abstract] [Full Text] [Related]

  • 60. Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition.
    Nikiforov MA, Riblett M, Tang WH, Gratchouck V, Zhuang D, Fernandez Y, Verhaegen M, Varambally S, Chinnaiyan AM, Jakubowiak AJ, Soengas MS.
    Proc Natl Acad Sci U S A; 2007 Dec 04; 104(49):19488-93. PubMed ID: 18042711
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.